Objectives: Information on the health care costs associated with nonadherence to treatments
for diabetes is both limited and inconsistent. We reviewed and critically appraised the …

Objective To assess the cost effectiveness of palivizumab (a preventative treatment against
severe respiratory syncytial virus [RSV] infection) in children at high risk of hospitalisation, ie …

Background Health-related quality of life is often collected in clinical studies, and forms a
cornerstone of economic evaluation. This study had two objectives, firstly to report and compare …

Introduction The goal of this study was to compare the efficacy in terms of Health Assessment
Questionnaire change from baseline (HAQ CFB), 50% improvement in American College …

Objective: The aim of this study was to estimate the cost-effectiveness of palivizumab, a
monoclonal antibody against severe respiratory syncytial virus infection, in high-risk infants in …

Background: Respiratory syncytial virus (RSV) is a common pathogen that is the leading
cause of lower respiratory tract infections in young children. High-risk children are at risk of …

… The author Maximillian Lebmeier, who was employed by the sponsor at the time, was … The
following author was employed by the sponsor at the time of analysis: Maximilian Lebmeier. …

Objectives: To assess the cost effectiveness of palivizumab, a humanised monoclonal antibody,
used as prevention against severe respiratory syncytial virus (RSV) infection requiring …

Objective. To compare the efficacy of abatacept and alternative biologic disease-modifying
antirheumatic drugs (DMARD) in patients with rheumatoid arthritis (RA) and an inadequate …

All stakeholders involved in the development, licencing, and market access of health care
technologies use stage-specific valuation matched that integrates risks and outcomes to …